121 related articles for article (PubMed ID: 10545416)
1. No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer.
Dunning AM; McBride S; Gregory J; Durocher F; Foster NA; Healey CS; Smith N; Pharoah PD; Luben RN; Easton DF; Ponder BA
Carcinogenesis; 1999 Nov; 20(11):2131-5. PubMed ID: 10545416
[TBL] [Abstract][Full Text] [Related]
2. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.
Ingles SA; Ross RK; Yu MC; Irvine RA; La Pera G; Haile RW; Coetzee GA
J Natl Cancer Inst; 1997 Jan; 89(2):166-70. PubMed ID: 8998186
[TBL] [Abstract][Full Text] [Related]
3. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
Wedrén S; Magnusson C; Humphreys K; Melhus H; Kindmark A; Stiger F; Branting M; Persson I; Baron J; Weiderpass E
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1775-83. PubMed ID: 17855696
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians.
Chakraborty A; Mishra AK; Soni A; Regina T; Mohil R; Bhatnagar D; Bhatnagar A; Chintamani C; Sharma PC; Saxena S
Cancer Detect Prev; 2009; 32(5-6):386-94. PubMed ID: 19588543
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk.
Andersson P; Varenhorst E; Söderkvist P
Eur J Cancer; 2006 Nov; 42(16):2833-7. PubMed ID: 17010601
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia.
Bousema JT; Bussemakers MJ; van Houwelingen KP; Debruyne FM; Verbeek AL; de La Rosette JJ; Kiemeney LA
Eur Urol; 2000 Feb; 37(2):234-8. PubMed ID: 10705205
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in southern Pakistani patients.
Iqbal Mu; Khan TA; Maqbool SA
PLoS One; 2015; 10(3):e0122657. PubMed ID: 25799416
[TBL] [Abstract][Full Text] [Related]
8. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ
Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380
[TBL] [Abstract][Full Text] [Related]
9. Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer.
Slattery ML; Sweeney C; Murtaugh M; Ma KN; Caan BJ; Potter JD; Wolff R
Int J Cancer; 2006 Jun; 118(12):3140-6. PubMed ID: 16425262
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk.
Sillanpää P; Hirvonen A; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K
Pharmacogenetics; 2004 Apr; 14(4):239-45. PubMed ID: 15083068
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.
Reimers LL; Crew KD; Bradshaw PT; Santella RM; Steck SE; Sirosh I; Terry MB; Hershman DL; Shane E; Cremers S; Dworakowski E; Teitelbaum SL; Neugut AI; Gammon MD
Cancer Causes Control; 2015 Feb; 26(2):187-203. PubMed ID: 25421379
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor gene polymorphisms and breast cancer risk.
Guy M; Lowe LC; Bretherton-Watt D; Mansi JL; Peckitt C; Bliss J; Wilson RG; Thomas V; Colston KW
Clin Cancer Res; 2004 Aug; 10(16):5472-81. PubMed ID: 15328186
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022
[TBL] [Abstract][Full Text] [Related]
14. Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population.
Patiño-García B; Arroyo C; Rangel-Villalobos H; Soto-Vega E; Velarde-Félix JS; Gabilondo F; Sandoval-Ramirez L; Figuera LE
Rev Invest Clin; 2007; 59(1):25-31. PubMed ID: 17569297
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
[TBL] [Abstract][Full Text] [Related]
16. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population.
Giguère Y; Dewailly E; Brisson J; Ayotte P; Laflamme N; Demers A; Forest VI; Dodin S; Robert J; Rousseau F
Cancer Res; 2001 Aug; 61(15):5869-74. PubMed ID: 11479228
[TBL] [Abstract][Full Text] [Related]
17. Association between vitamin D receptor (VDR) gene polymorphisms and systemic lupus erythematosus in Portuguese patients.
Carvalho C; Marinho A; Leal B; Bettencourt A; Boleixa D; Almeida I; Farinha F; Costa PP; Vasconcelos C; Silva BM
Lupus; 2015 Jul; 24(8):846-53. PubMed ID: 25661837
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor gene polymorphisms in breast cancer.
Buyru N; Tezol A; Yosunkaya-Fenerci E; Dalay N
Exp Mol Med; 2003 Dec; 35(6):550-5. PubMed ID: 14749534
[TBL] [Abstract][Full Text] [Related]
20. [Case-control study of the genes of receptors of the androgens of vitamin-D and of 5-alphareductase in a population of Afro-Caribbean population with prostate cancer].
Veronique-Baudin J; Dieye M; Kouyoumdjian JC; Vacheron F; Draganescu C; Azaloux H
Prog Urol; 2006 Jun; 16(3):303-10. PubMed ID: 16821341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
